logo

Health News

vitamind-jan31.jpgVitamin D is very essential for healthy bones and to prevent osteoporosis. Known as the "Sunshine Vitamin, as sunlight is the main source, the deficiency of Vitamin D has been associated with fatigue, depressed mood and bone, and muscle pain, to name a few.
Read More

Drugstore chain CVS Health Corp. (CVS) has started selling cannabidiol or CBD products in eight states in the U.S., according to media reports on Wednesday. The products reportedly being sold by the company include topicals such as CBD sprays, roll-ons, creams, lotions and salves. The products are...
Read More
fluemen-july19.jpg Women are said to experience a more severe outcome from influenza A virus infection and recover slower than men, even when the viral load is the same in both the genders. Read More

Alzheimer's Tau Protein Raises Risk Of Cancer Too: Study



One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More
adhd-july18.jpg

Frequent Use Of Digital Media Linked To ADHD Symptoms In Adolescents, Says Study



Frequent use of digital media is associated with the development of attention-deficit/hyperactivity disorder (ADHD) symptoms during adolescence, finds a new study conducted by a team of researchers of the University of Southern California.
Read More
thalidomidebabies-aug06.jpgThalidomide babies or Thalidomide disaster. Do these terms sound familiar? Understanding the mechanism of Thalidomide-induced birth defects has always been of interest to the scientific community. Now, scientists at the Dana-Farber Cancer Institute have finally found an answer.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
06/21/19AGIOTIBSOVO (sNDA)FDA decision on TIBSOVO for newly diagnosed acute myeloid leukemia with IDH1 mutation
06/10/19MRKKEYTRUDA (sBLA)FDA decision on KEYTRUDA as Monotherapy or in combination with Chemotherapy
05/28/19NKTRNKTR-181 (NDA)FDA decision on NKTR-181 for chronic low back pain in adult patients new to opioid therapy
04/30/19HRTXHTX-011 (NDA)FDA decision on HTX-011 for the management of postoperative pain
04/30/19NBRVCONTEPO (NDA)FDA decision on CONTEPO IV for the treatment of complicated urinary tract infections
04/28/19SNYNF, SNYPraluent (sBLA)FDA decision to include the effect of Praluent in reducing overall risk of major adverse cardiovascular events
View All